Source: International Congress 2018 – Integrated care for patients with pulmonary vascular disease, lung diseases and heart failure
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Humbert (Paris, France). Optimising pharmacotherapy in patients with pulmonary arterial hypertension and comorbidities, including lung diseases and heart failure: benefits without harm?. International Congress 2018 – Integrated care for patients with pulmonary vascular disease, lung diseases and heart failure

Member's Comments

No comment yet.

Related content which might interest you: Hospitalization in patients with pulmonary arterial hypertension: causes and outcomes Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Audit of disease targeted therapies in adult patients with pulmonary arterial hypertension Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension Year: 2017 Systemic manifestations and comorbidities of COPD Source: Eur Respir J 2009; 33: 1165-1185 Year: 2009 Chronic thromboembolic pulmonary hypertension Source: Eur Respir Mon 2012; 57: 108-118 Year: 2012 Interdisciplinary rehabilitation in pulmonary hypertension: can we learn from chronic obstructive pulmonary disease or heart failure? Source: International Congress 2018 – Integrated care for patients with pulmonary vascular disease, lung diseases and heart failure Year: 2018 Risk assessment, therapy and cardiovascular comorbidity in patients with pulmonary arterial hypertension Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 The beta-blockers in combined treatment of coronary heart disease in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –COPD treatment Year: 2013 Frequency of adverse consequences after spirography in patients with chronic obstructive pulmonary disease and concomitant ischemic heart disease Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Short-term outcomes in community heart failure patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - Comorbidities and management in primary care Year: 2011 Bosentan treatment for pulmonary arterial hypertension related to congenital heart disease: real-world clinical experience in Spain Source: Annual Congress 2009 - Pulmonary hypertension Year: 2009 Do cardiovascular drugs reduce mortality in patients with COPD in daily practice? A study in primary care Source: Annual Congress 2007 - Management of COPD: pushing forward the boundaries in primary care Year: 2007 Underrepresentation of patients with cardiovascular diseases in trials of chronic obstructive pulmonary disease: Transferability problems in general practice? Source: Annual Congress 2010 - Management of airway disease Year: 2010 Pulmonary hypertension associated with left heart disease: efforts to improve the meaning of haemodynamic phenotypes Source: Eur Respir J, 53 (3) 1801894; 10.1183/13993003.01894-2018 Year: 2019 Pulmonary hypertension associated with left heart disease: efforts to improve the meaning of haemodynamic phenotypes Source: Eur Respir J, 53 (3) 1802393; 10.1183/13993003.02393-2018 Year: 2019 Managing chronic thromboembolic pulmonary hypertension: pharmacological treatment options Source: Eur Respir Rev 2009; 18: 24-28 Year: 2009 The effects of beta-blocker therapy on heart rate, symptoms and exercise in pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment Year: 2013 Quantify comorbidities burden of chronic obstructive pulmonary disease patients using medication regimen complexity index Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 The association of diuretics treatment with hospitalization rates of patients with chronic obstructive pulmonary disease and pulmonary hypertension: a population-based study Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Should all chronic obstructive pulmonary disease (COPD) patients with cardiac co-morbidities have ambulatory oxygen assessment? Source: Annual Congress 2008 - Exercise: system responses Year: 2008